Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 20001-20050 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02088554
PERIGON Pivotal Trial
NAActive, not recruiting
1,312 participants
Started: May 12, 2014 · Completed: Dec 31, 2035
1 condition2 sponsors38 locations
NCT02094794
Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML
PHASE2Active, not recruiting
108 participants
Started: May 12, 2014 · Completed: May 26, 2026
10 conditions2 sponsors1 location
NCT03604406
The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept
PHASE2Active, not recruiting
154 participants
Started: May 8, 2014 · Completed: Feb 28, 2026
3 conditions3 sponsors5 locations
NCT02125786
A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
PHASE2Active, not recruiting
68 participants
Started: May 7, 2014 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT03199196
Using Social Networks to Promote Physical Activity in African American and Hispanic Women
NAActive, not recruiting
101 participants
Started: May 2, 2014 · Completed: May 30, 2026
1 condition1 sponsor2 locations
NCT04092933
Perioperative Risk Calculator
N/AActive, not recruiting
175,559 participants
Started: May 1, 2014 · Completed: Dec 31, 2024
1 condition2 sponsors0 locations
NCT02137005
Cerebral Palsy Adult Transition Longitudinal Study
N/AActive, not recruiting
72 participants
Started: May 1, 2014 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06079086
Evaluation of the Clinical Evolution of Breast Increase Using Prostheses
NAActive, not recruiting
60 participants
Started: May 1, 2014 · Completed: May 30, 2024
2 conditions1 sponsor0 locations
NCT02124421
HOT: HIPEC in Ovarian Cancer as Initial Treatment
PHASE2Active, not recruiting
32 participants
Started: Apr 30, 2014 · Completed: Apr 30, 2028
7 conditions1 sponsor1 location
NCT02270359
Research on Infarction With Open Arteries Using OCT and CMR
NAActive, not recruiting
15 participants
Started: Apr 30, 2014 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT02077335
Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer
PHASE2Active, not recruiting
50 participants
Started: Apr 30, 2014 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT02041936
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System
NAActive, not recruiting
4 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02056769
CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage
NAActive, not recruiting
41 participants
Started: Apr 30, 2014 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT02104310
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
N/AActive, not recruiting
25 participants
Started: Apr 30, 2014 · Completed: Mar 31, 2031
1 condition2 sponsors1 location
NCT02206360
Pancreatic Cancer Early Detection Program
N/AActive, not recruiting
100 participants
Started: Apr 30, 2014 · Completed: Jun 30, 2024
11 conditions1 sponsor1 location
NCT02134054
Stavanger IBD Study - Cross Sectional
N/AActive, not recruiting
210 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT02087826
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
NAActive, not recruiting
1,017 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT02115724
Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
NAActive, not recruiting
74 participants
Started: Apr 30, 2014 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT05523856
New Treatment Modalities for Localized Prostate Cancer
N/AActive, not recruiting
480 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2027
1 condition15 sponsors0 locations
NCT02050347
Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)
PHASE1Active, not recruiting
7 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2030
3 conditions3 sponsors2 locations
NCT02123641
Physical Activity as Intervention Against Age-related Loss of Muscle Mass and Function
NAActive, not recruiting
451 participants
Started: Apr 30, 2014 · Completed: Jun 30, 2028
4 conditions3 sponsors1 location
NCT02213497
Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
PHASE1Active, not recruiting
30 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02106611
Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors
N/AActive, not recruiting
133 participants
Started: Apr 30, 2014 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT01953900
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
PHASE1Active, not recruiting
26 participants
Started: Apr 30, 2014 · Completed: Oct 31, 2034
2 conditions4 sponsors2 locations
NCT03301168
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
PHASE1/PHASE2Active, not recruiting
120 participants
Started: Apr 30, 2014 · Completed: May 31, 2034
9 conditions1 sponsor10 locations
NCT01888601
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
N/AActive, not recruiting
814 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2026
1 condition2 sponsors18 locations
NCT01915615
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
N/AActive, not recruiting
2,750 participants
Started: Apr 30, 2014 · Completed: Jun 30, 2025
1 condition3 sponsors44 locations
NCT02170090
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
PHASE3Active, not recruiting
789 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2025
2 conditions5 sponsors67 locations
NCT02015117
Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases
PHASE1Active, not recruiting
10 participants
Started: Apr 28, 2014 · Completed: Oct 8, 2026
1 condition1 sponsor1 location
NCT03182335
Vasopressor SAT Study
N/AActive, not recruiting
800 participants
Started: Apr 28, 2014 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT02935400
Acute Porphyria Biomarkers for Disease Activity
N/AActive, not recruiting
50 participants
Started: Apr 28, 2014 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT02068794
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
PHASE1/PHASE2Active, not recruiting
34 participants
Started: Apr 25, 2014 · Completed: Dec 1, 2025
18 conditions2 sponsors1 location
NCT02032823
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
PHASE3Active, not recruiting
1,837 participants
Started: Apr 22, 2014 · Completed: May 28, 2029
1 condition7 sponsors698 locations
NCT02105766
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
PHASE2Active, not recruiting
56 participants
Started: Apr 21, 2014 · Completed: Dec 31, 2027
4 conditions3 sponsors1 location
NCT02135042
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
PHASE2/PHASE3Active, not recruiting
685 participants
Started: Apr 21, 2014 · Completed: Feb 28, 2031
5 conditions2 sponsors215 locations
NCT01959698
Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
PHASE1Active, not recruiting
29 participants
Started: Apr 17, 2014 · Completed: Dec 1, 2025
7 conditions3 sponsors1 location
NCT02122107
Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History
N/AActive, not recruiting
499 participants
Started: Apr 8, 2014 · Completed: Apr 30, 2026
1 condition3 sponsors2 locations
NCT02299999
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
PHASE2Active, not recruiting
1,460 participants
Started: Apr 7, 2014 · Completed: Dec 31, 2025
1 condition3 sponsors25 locations
NCT04214756
Methodist Acute Pancreatitis Protocol
N/AActive, not recruiting
500 participants
Started: Apr 5, 2014 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT02106598
Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases
PHASE1/PHASE2Active, not recruiting
67 participants
Started: Apr 3, 2014 · Completed: Apr 30, 2026
1 condition1 sponsor2 locations
NCT02023463
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
PHASE1Active, not recruiting
25 participants
Started: Apr 2, 2014 · Completed: Jan 1, 2040
5 conditions3 sponsors1 location
NCT02118649
Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game
NAActive, not recruiting
100 participants
Started: Apr 1, 2014 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04812353
Foot and Ankle Arthrodesis or Osteotomy With Io-Fix Type Fixation
NAActive, not recruiting
208 participants
Started: Apr 1, 2014 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT02076113
Cervical Spondylotic Myelopathy Surgical Trial
NAActive, not recruiting
269 participants
Started: Apr 1, 2014 · Completed: Dec 30, 2025
1 condition2 sponsors16 locations
NCT02096159
Prophylactic Antibiotics or Placebo After Hypospadias Repair
NAActive, not recruiting
93 participants
Started: Mar 31, 2014 · Completed: Aug 31, 2025
1 condition2 sponsors2 locations
NCT02038140
Zimmer Trabecular Metal Total Ankle PMCF
NAActive, not recruiting
120 participants
Started: Mar 31, 2014 · Completed: Mar 31, 2027
3 conditions1 sponsor11 locations
NCT02091245
Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML
PHASE1Active, not recruiting
16 participants
Started: Mar 31, 2014 · Completed: Dec 31, 2025
9 conditions3 sponsors10 locations
NCT02149030
Effectiveness of Cervical Screening in HPV Vaccinated Women
NAActive, not recruiting
6,958 participants
Started: Mar 31, 2014 · Completed: Jan 31, 2025
1 condition4 sponsors31 locations
NCT01903330
ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PHASE2Active, not recruiting
84 participants
Started: Mar 31, 2014 · Completed: Jun 30, 2026
2 conditions2 sponsors3 locations
NCT02446405
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
PHASE3Active, not recruiting
1,125 participants
Started: Mar 31, 2014 · Completed: Jun 30, 2027
1 condition5 sponsors82 locations